Urological Cancer 2023-2025

This collection contains a total of nine contributions in the area of urological cancer collected in the 2023–2025 period. It includes 5 papers (5 articles) focusing on different aspects of urinary tract neoplasia, 2 papers (1 review and 1 article) on kidney cancer, and 2 papers (1 review and 1 article) on prostate cancer. This Special Issue includes reviews on new molecular techniques for detecting prostate cancer on urine sediment, T-cell engagers therapies for prostate cancer, post-BCG upper urinary tract cancer survival, the usefulness of patient-reported symptoms and functional outcomes after radical cystectomy for bladder cancer, intraoperative magnetic resonance imaging in children with bladder/prostate rhabdomyosarcoma, prognostic factors in platinum-refractory urothelial carcinoma treated with pembrolizumab, new approaches of HIF-2α targeted therapies in metastatic renal cell carcinoma, and CKAP4 expression in the prognosis of bladder cancer patients. Also, a novel approach to the early evolution of clear cell renal cell carcinoma using mathematical tools (game theory) is included in this volume. Medical specialists and scientists from Japan, USA, Spain, Italy, Brazil, Germany, Portugal, and the UK have participated in this collection. Interested readers will find excellent updated reviews of the most relevant topics in the diagnosis, prognosis, and treatment of urological cancer.